Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Tph cells are linked to the severity of systemic lupus erythematosus.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

A risk prediction model can help diagnose systemic lupus erythematosus earlier in primary care.

COVID-19 vaccination may trigger lupus in some people.

SLE is more common among Nigerians than previously thought, especially in women, requiring early treatment.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Prednisone may cause multiple skin nodules in lupus patients.

Hair loss in lupus patients indicates higher disease activity.

PUVA treatment may have triggered lupus in a woman with psoriasis.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

SLE should be considered in horses with immune-related skin issues.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Protein-losing enteropathy worsened with lupus symptoms but improved with prednisolone.

A woman with lupus and severe nerve damage improved with specific treatments.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.